Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 42%
Hold 16%
Sell 0%
Strong Sell 5%

Bulls say

Intuitive Surgical is a global technology leader in robotic-assisted, minimally invasive surgery with over 10,000 da Vinci systems placed worldwide. The company's strong financial performance, including an operating margin of 38.9%, and increased procedure volume in the US and internationally, are key indicators of its continued success and potential for future growth. The recent launch of a new Dv5 system, along with continued innovation and expansion in the ecosystem, further demonstrates Intuitive's commitment to improving surgical outcomes and driving adoption of their technology.

Bears say

Intuitive Surgical is facing pressure from peers in the medical technology industry, resulting in a compressed valuation multiple of 50x for its FY27 adjusted forecast. While the company continues to see strong global demand for its da Vinci system, especially in emerging markets, its growth rate has only slightly exceeded expectations. Additionally, both the SP and Ion systems are experiencing converging utilization rates, which could limit potential for further growth.

Intuitive Surgical (ISRG) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 42% recommend Buy, 16% suggest Holding, 0% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 19 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $591.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $591.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.